Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 2, 2022
Patent Application Number
16627968
Date Filed
July 9, 2018
Patent Citations
Patent Primary Examiner
The invention relates to improved binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
